Laurus Labs Ltd.NSE: LAURUSLABS

Press Release Jun 19 2023

· Issued by Laurus Labs Ltd.

Filed with NSE · · 3 pages · English

Summary by 6ix AI

Laurus Labs Ltd. has signed a Memorandum of Agreement with IIT Kanpur to develop novel gene therapy assets. The agreement includes in-licensing gene therapy assets and funding for pre-clinical and clinical trials. Laurus Labs will also establish a GMP facility at IIT Kanpur's Techno Park. This partnership aims to enhance access to gene therapies in India and emerging markets. The CEO expressed excitement about the collaboration's potential to provide affordable treatments.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Laurus Labs Ltd. on 6ix

Earlier from Laurus Labs

Later from Laurus Labs

All Laurus Labs news releases